OBJECTIVES: To discuss the history, current state, and future directions of umbilical cord blood (UCB) transplantation as it relates to the emerging field of cellular therapies. DATA SOURCES: Research studies, articles, and personal experiences. CONCLUSION: Transplantation using hematopoietic stem cells from UCB is a life-saving option for patients with select oncologic and immunologic diseases, bone marrow failure, hemoglobinopathies, and inborn errors of metabolism.
OBJECTIVES: To discuss the history, current state, and future directions of umbilical cord blood (UCB) transplantation as it relates to the emerging field of cellular therapies. DATA SOURCES: Research studies, articles, and personal experiences. CONCLUSION: Transplantation using hematopoietic stem cells from UCB is a life-saving option for patients with select oncologic and immunologic diseases, bone marrow failure, hemoglobinopathies, and inborn errors of metabolism.
Authors: Louiza Z Karagiorgou; Maria-Nikoletta P Pantazopoulou; Nikolaos C Mainas; Apostolos I Beloukas; Anastasios G Kriebardis Journal: Blood Transfus Date: 2013-10-03 Impact factor: 3.443
Authors: Nicolas H Zech; Nikolas Broer; Iris Ribitsch; Mathias H Zech; Karl-Heinz Broer; Kubilay Ertan; Karl-Heinz Preisegger Journal: J Turk Ger Gynecol Assoc Date: 2010-06-01